Plazomicin

Plazomicin (trade name Zemdri) is an antibiotic used to treat complicated urinary tract infections caused by certain bacteria. It is in the class of antibiotics known as aminoglycosides and works by inhibiting bacterial protein synthesis. Plazomicin is usually given as an intravenous (IV) infusion every 24 hours for 7 to 14 days. It is usually used in combination with other antibiotics. Common side effects include nausea, vomiting, diarrhea, headache, and rash.

Plazomicin is an antibiotic medication used to treat serious infections caused by certain multi-drug resistant bacteria. Here's a breakdown of its key points:

  • Antibiotic class: Aminoglycoside [National Institutes of Health]
  • Effectiveness: Particularly effective against gram-negative bacteria, including some strains resistant to other antibiotics [National Institutes of Health].

Important things to remember about Plazomicin:

  • Reserved for serious infections: Due to its potential side effects and to help preserve its effectiveness against resistant bacteria, Plazomicin is typically reserved for severe infections unresponsive to other antibiotics [National Institutes of Health].
  • Serious side effects: Plazomicin can cause serious side effects, including hearing loss, kidney damage, and nerve problems [National Institutes of Health]. Close monitoring by a healthcare professional is essential during treatment.
  • Prescription drug: Only available with a doctor's prescription and administered intravenously (through a vein) in a healthcare setting [National Institutes of Health].
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J01 Antibacterials for systemic use
J01G - Aminoglycoside antibacterials
J01GB Other aminoglycosides
External Links